Share
CNBC Pro

Full interview with Eli Lilly CEO David Ricks on positive Covid-19 treatment data

Eli Lilly said on Monday its rheumatoid arthritis drug baricitinib shortened the time taken to recover from Covid-19 in hospitalized patients when taken in combination with Gilead Sciences' antiviral remdesivir. Eli Lilly CEO David Ricks joined "Squawk Box" to discuss the trial results.
05:55
Mon, Sep 14 20209:27 AM EDT

watch now
VIDEO45:13
CNBC ProWatch Monday's full episode of Mad Money with Jim Cramer — April 12, 2021
watch now
VIDEO10:28
CNBC ProJim Cramer breaks down the 'last man standing scenario'
watch now
VIDEO06:43
CNBC ProStart-up Recur aims to help brands connect with audiences through NFTs
watch now
VIDEO44:26
CNBC ProWatch Monday's full episode of Fast Money — April 12, 2021
watch now
VIDEO09:23
CNBC ProJim Cramer recommends Honeywell, Boeing as aerospace heats up